← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 11, 2023Last known activity
Dec 31, 2025
Timeline
2010s
- Jan 1, 2019
Eikon Therapeutics— Founded
Drugs by trial phase (8 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Recent trials (9)
- NCT07262619Lead sponsorPhase 1/Phase 2Dec 31, 2025
- NCT06907043Lead sponsorPhase 1/Phase 2Apr 30, 2025
- NCT06907043OfficialPhase 1/Phase 2Apr 30, 2025
- NCT06697301Lead sponsorPhase 2/Phase 3Nov 30, 2024
- NCT06697301OfficialPhase 2/Phase 3Nov 30, 2024
- NCT06246110Lead sponsorPhase 2Feb 6, 2024
- NCT06246110OfficialPhase 2Feb 6, 2024
- NCT06253130Lead sponsorPhase 1/Phase 2Dec 11, 2023
- NCT06253130OfficialPhase 1/Phase 2Dec 11, 2023
Details
- Founded
- Hayward, CA, US Jan 1, 2019
- Last known activity
- Dec 31, 2025